SOHO 3rd Italian Conference
Avatar

SOHO Italy 2021 on MM: State of the Art Therapy in Europe

By SOHO 3rd Italian Conference FEATURING Claudio Cerchione
January 5, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

06:56
Sanofi

Autologous HCT in Older Adults with MM: Eligibility Assessment

Feat. T. Wildes

Featured Video

06:53
Sanofi

Geographic and Socioeconomic Disparities in HCT Access for MM: Impac…

Feat. L. Costa

Related Content

AUTOPLAY
06:53
Sanofi

Geographic and Socioeconomic Disparities in HCT Access for MM: Impac…

Feat. L. Costa
06:56
Sanofi

Autologous HCT in Older Adults with MM: Eligibility Assessment

Feat. T. Wildes
24:19
Dana-Farber Cancer Institute

Phase 3 DETERMINATION Trial: RVd ± ASCT & Lenalidomide Maintenan…

Feat. P. Richardson
10:29
Mary Kwok

Moving to Quadruplets in NDMM

31:36
Nebraska Oncology Society

ASCO 2022 on Moving Toward a Cure in Myeloma: The Role of MRD Testing

Feat. A. Nooka
34:28
2022 Community Oncology Conference

Treatment Conundrums in Myeloma

Feat. S. Giralt
17:59
Parameswaran Hari

Delivering the Best Initial Treatment for Myeloma: Induction Therapy…

33:28
Cleveland Clinic Taussig Cancer Institute

Management of Relapsed/Refractory Multiple Myeloma

Feat. F. Anwer
15:12
Yale Cancer Center

ASH 2021: Cellular Therapies in Myeloma

Feat. N. Bar
10:40
Claudio Cerchione

Frontline MM State of the Art: Can We Prolong PFS With D-VTd in ASCT…

26:05
SOHO Italy 1st School of Multiple Myeloma

Introducing Anti-CD38 in Daily Practice of MM: Updates on the GRIFFI…

Feat. C. Cerchione
16:57
SOHO Italy 1st School of Multiple Myeloma

Anti-CD38 in MM Daily Practice: How Can We Potentiate the Action of …

Feat. C. Cerchione
15:57
SOHO 3rd Italian Conference

SOHO Italy 2021 on CAR T in MM: Preliminary Data and Perspectives

Feat. C. Cerchione
01:29
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Addition of Carfilzomib as a Thir…

Feat. C. Cerchione
04:29
ecancer

EHA 2022 on a Phase III GMMG-HD7 Trial: Isa-RVd as Induction Therapy…

Feat. E. Mai
23:18
Oncology Data Advisor

Can Diet and Nutrition Impact Multiple Myeloma Outcomes?

Feat. U. Shah, R. Banerjee
19:13
SOHO Italy 1st School of Multiple Myeloma

Daratumumab in MM Daily Practice: Is It Becoming the New Backbone?

Feat. C. Cerchione
15:24
SOHO 3rd Italian Conference

SOHO Italy 2021 on R/R MM Treatment in Europe

Feat. C. Cerchione
05:05
ASCO 2022 Conference Coverage

ASCO 2022 on Elranatamab, a BCMA-Targeted T-Cell Redirecting Immunot…

Feat. A. Jakubowiak
06:50
ecancer

EHA 2021 Highlights on KRd for Lenalidomide-Refractory MM

Feat. C. Cerchione